BiotechTube

Pexidartinib + Probenecid

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pharmacokinetics in Healthy Volunteers

Conditions

Pharmacokinetics in Healthy Volunteers

Trial Timeline

Feb 27, 2017 → Mar 30, 2017

NCT ID
NCT03138759

About Pexidartinib + Probenecid

Pexidartinib + Probenecid is a phase 1 stage product being developed by Daiichi Sankyo for Pharmacokinetics in Healthy Volunteers. The current trial status is completed. This product is registered under clinical trial identifier NCT03138759. Target conditions include Pharmacokinetics in Healthy Volunteers.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT03138759Phase 1Completed

Competing Products

20 competing products in Pharmacokinetics in Healthy Volunteers

See all competitors
ProductCompanyStageHype Score
GP30341 capsules 200 mg + Standard therapyGEROPHARMPre-clinical
15
GP40221 + ozempicGEROPHARMPhase 1
25
Memantinol tablets, 20 mg + Akatinol Memantine® tablets, 20 mgGEROPHARMPhase 1
25
Rinsulin NPH + Humulin NPHGEROPHARMPre-clinical
15
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
33
DS-8500a + ItraconazoleDaiichi SankyoPhase 1
33
Milademetan + Itraconazole + PosaconazoleDaiichi SankyoPhase 1
33
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
33
DS-8500aDaiichi SankyoPhase 1
33
Milademetan Treatment A + Milademetan Treatment B + Milademetan Treatment CDaiichi SankyoPhase 1
33
tolterodine + mirabegronAstellas PharmaApproved
85
ASP3652Astellas PharmaPhase 1
33
ASP015K ER + ASP015K IRAstellas PharmaPhase 1
33
YM178 modified release (OCAS) + YM178 immediate release (IR)Astellas PharmaPhase 1
33
Isavuconazole + dextromethorphanAstellas PharmaPhase 1
33
mirabegron + metoprololAstellas PharmaPhase 1
33
ASP015KAstellas PharmaPhase 1
33
zolbetuximab + oxaliplatin + leucovorin + fluorouracil + Pembrolizumab + folinic acid + nivolumab + DocetaxelAstellas PharmaPhase 2
52
Isavuconazole + Repaglinide + CaffeineAstellas PharmaPhase 1
33
mirabegron + rifampinAstellas PharmaPhase 1
33

Other Products from Daiichi Sankyo

Olmesartan medoxomil + Olmesartan medoxomil/hydrochlorothiazide + HydrochlorothiazideApproved
85
OAC aloneApproved
85
olmesartan medoxomil + Placebo + losartan potassiumApproved
85
Prasugrel + ClopidogrelApproved
85
Diet+pravastatinApproved
85